课题基金 / 基金详情

Identification of a tumor suppressor gene of malignant mesothelioma and functional analysis of the NF2 and p16 genes

Identification of a tumor suppressor gene of malignant mesothelioma and functional analysis of the NF2 and p16 genes
恶性间皮瘤抑癌基因的鉴定及NF2和p16基因的功能分析
批准号:
12670556
负责人:
SEKIDO Yoshitaka
金额:
$0.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

SEKIDO Yoshitaka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To isolate a new tumor suppressor gene of human malignant mesothelioma, we searched for the abnormalities of chromosome 3p showing frequent loss of heterozygosity and identified that the β-catenin gene (CTNNB1), located at 3p21.33, is homozygously deleted in a malignant mesothelioma cell line, NCI-H28. We constructed a genomic DNA library from NCI-H28, and identified that the breakpoint of the homozygous region was located in intron 1 of β-catenin, which was rearranged to another region located at 3p21, rbc. We further cloned a new gene (MTSK1) of 4153 bp from this region and found that this putative protein product contains a kinase motif at the amino terminal. Northern blot analysis demonstrated that its message sizes are 4.7 and 2.1 kb and that MTSK1 is expressed in the testis at a high level but at low levels in other tissues. We studied for the mutation in 9 malignant mesotheliomas and 68 lung cancers by PCR-SSCP analysis and identified several aberrant mobility shifts, which are now being characterized by sequencing. A protein analysis is also scheduled in the future with antibodies that are under synthesis against MTSK1. Meanwhile, we established new malignant mesothelioma cell lines, Y-Meso8A and Y-Meso8B, from a patient and tested tumorigenecity of these cell lines by transplantation in nude mice. Mutational analysis for tumor suppressor genes (NF2, p16, p53, E-cadherin) and oncogene (KRAS, NRAS, and MDM2) showed that these cell lines do not harbor either mutations of these genes.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Shigemitsu Kikuo: "Genetic alteration of the β-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion"Oncogene. 20. 4249-4257 (2001)
Shigemitsu Kikuo:“人类肺癌和恶性间皮瘤中 β-连环蛋白基因 (CTNNB1) 的遗传改变和新 3p21.3 纯合缺失的鉴定”Oncogene。20. 4249-4257 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shigemitsu Kikuo: "Genetic alteration of the β-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion"Oncogene. 20 :. 4249-4257 (2001)
Shigemitsu Kikuo:“人类肺癌和恶性间皮瘤中 β-连环蛋白基因 (CTNNB1) 的遗传改变和新 3p21.3 纯合缺失的鉴定”Oncogene 20:4249-4257 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Development of novel molecular diagnostic and therapeutic tools based on genomic information of malignant mesothelioma
  • 批准号:
    16H04706
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.73万
  • 财政年份:
    2016
  • 负责人:
    SEKIDO Yoshitaka
  • 依托单位:
Development of a new therapeutic tool against malignant mesothelioma
  • 批准号:
    24650650
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.5万
  • 财政年份:
    2012
  • 负责人:
    SEKIDO Yoshitaka
  • 依托单位:
Identification of genetic alterations in malignant mesothelioma and the development of new molecular diagnostic tools
  • 批准号:
    22300338
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.07万
  • 财政年份:
    2010
  • 负责人:
    SEKIDO Yoshitaka
  • 依托单位:
Identification of new therapeutic target molecules and development of diagnostic markers for malignant mesothelioma
  • 批准号:
    18390245
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.53万
  • 财政年份:
    2006
  • 负责人:
    SEKIDO Yoshitaka
  • 依托单位:
海外基金